Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Risk factors for early postoperative cognitive dysfunction after non-coronary bypass surgery in Chinese population

  • Tao Xu1,
  • Lulong Bo1,
  • Jiafeng Wang1,
  • Zhenzhen Zhao1,
  • Zhiyun Xu2,
  • Xiaoming Deng1 and
  • Wenzhong Zhu1Email author
Contributed equally
Journal of Cardiothoracic Surgery20138:204

https://doi.org/10.1186/1749-8090-8-204

Received: 23 March 2013

Accepted: 28 October 2013

Published: 1 November 2013

Abstract

Background

The present study was performed to investigate the incidence of early postoperative cognitive dysfunction (POCD) after non-coronary bypass surgery and the potential risk factors in Chinese population.

Methods

We performed a prospective study in a teaching tertiary hospital from May 2012 to August 2012. One hundred and seventy-six adult patients undergoing non-coronary bypass surgery were recruited. Mini-Mental State Examination (MMSE) score was evaluated before and 3 to 5 days after surgery. Patients with a MMSE score reduction of 2 was diagnosed with POCD.

Results

The general incidence of POCD was 33.0%, with no significant difference between the types of surgeries. In the univariate analysis, POCD associated factors included age, duration of surgery, anesthesia, cardiopulmonary bypass (CPB), cross-clamp and rewarming, and sevoflurane concentration. However, only age, cross-clamp duration and sevoflurane concentration were demonstrated to be independent risk factors for POCD.

Conclusion

Incidence of early POCD after non-coronary bypass surgery was relatively high in Chinese population. Advanced age, longer aortic cross-clamp duration and lower sevoflurane concentration was associated with a higher incidence of POCD.

Keywords

Postoperative cognitive dysfunctionCardiovascular surgeryRisk factorSevoflurane

Background

Postoperative cognitive dysfunction (POCD) is a common neurologic complication after cardiovascular surgery with an incidence varying between 33% and 83% [13]. A considerable proportion of patients with POCD (7 ~ 69%) do not recover in 3 months after surgery [4, 5]. Although the cognitive changes was not manifested clinically in some patients, it may lead to prolonged hospital stay, elevated medical cost, increased morbidity, declined life quality and readmission to hospital [6].

Although POCD has been concerned by cardiovascular surgeons and anesthesiologists since 1950s, the exact etiology of POCD remains unclear. It was found that brain swelling develops in 4 days after cardiopulmonary bypass (CPB) and tends to disappear at the end of first postoperative week [79]. Beside the structure changes, both electroencephalograph (EEG) and P300 latency of evoked cognitive potential show functional change after CPB too [10, 11]. Unfortunately, all of brain changes that previously observed did not clarify the pathogenesis of POCD completely. What’s more, those of changes did not parallel with cognitive status. It was reported that intraoperative hypotension and multiple microembolization are major reasons for POCD development [12, 13]. But in clinical settings, previous research revealed that multiple risk factors were associated with cognitive deterioration after cardiac surgery, such as left ventricular function, presence of diabetes, duration of anesthesia, a second operation, age and a history of neurologic disease and so on [1417]. These issues were thought to be susceptible to intraoperative hypotension and microembolization which leaded to POCD.

However, most of the data in previous studies were derived from coronary artery bypass graft (CABG) surgeries. As most of cardiovascular surgeries are performed on pump, such as congenital heart disease and rheumatic valve disease, the patients are also confronted with intraoperative hypotension and multiple microembolization. Therefore, patients undergoing cardiovascular surgeries other than CABG experienced similar pathophyisologic risks responsible for POCD. However, there were few reports of POCD after non-coronary bypass surgery. On the other hand, there may be differences in anatomy of brain vessels between the Chinese and the Caucasian [18, 19]. It is unclear whether there is any differences in the incidence of POCD in Chinese population.

The objective of this study was to evaluate the general incidence of early POCD after non-CABG cardiovascular surgery and discuss the clinical factors associated with early POCD in first postoperative week which influence the patients without a history of neurologic disease.

Methods

The study was approved by the special committee on ethics of biomedicine research of our university and written informed consent was obtained from all patients.

A total of 182 patients undergoing non-coronary bypass surgery were included in this study from May 2012 to August 2012. Inclusion criteria were defined as follows: (1) scheduled for a cardiovascular surgery, (2) at least 18 years old and (3) be able to speak and read Chinese. Exclusion criteria were as follows: (1) Mini-Mental State Examination (MMSE) score < 24 before surgery, (2) emergency cases, (3) a history of drug or alcohol abuse, (4) a history of psychiatric disorder, (5) history of a neurologic disease (including stroke history),(6) previously undergone neuropsychological testing, (7) had any severe visual or auditory disorders, (8) had Parkinson’s disease, (9) were unwilling to comply with the protocol or procedures.

Patients were interviewed in their hospital unit one day before the surgery. Test was carried out in quiet rooms and the patient and investigator were present. If the patient could not be tested in the test room, a quiet setting on the ward would be found for the test. All neuropsychological evaluations were conducted by trained research assistants. The training of the research assistants took an average of 72 hours, and supervision was performed throughout the project. The evaluation took an average of 50 minutes to complete and the second time was performed in the hospital unit during the period of 3 day to 5 day after surgery. The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language. A control group was established involving 16 patients with valvular diseases who did not receive surgical treatment for the z value calculation. The formula for z score calculation is as follows: z score = ([change score] – [mean change scorecontrol])/(standard deviation change scorecontrol). POCD was defined as a MMSE deterioration of 1 z score [15, 17].

Patients did not receive premedication. In the operating room, standard monitoring was used, including a 5-lead electrocardiogram, digital pulse oximeter, capnography, radial arterial catheter. Anesthesia was induced with midazolam (0.07 ~ 0.1 mg/kg), sulfentanyl (0.7 ~ 1.0 μg/kg), rocuronium (0.6 ~ 0.9 mg/kg) and etomidate (0.3 ~ 0.4 mg/kg). Intubation was done after induction administration over 1 min. Ventilation support was given immediately after intubation with O2 in air (60%). Anesthesia was maintained with sevoflurane and intravenous infusion of sulfentanyl (0.8 μg/kg/h) and cisatracurium (0.2 mg/kg/h), and supplemental bolus of intravenous sulfentanyl, midazolam, and rocuronium administered before skin incision, sternotomy, aortic cannulation, and sternal retraction.

Surgery procedures were classified as on-pump valve replacement, valvuloplasty, Bentall procedures, and repair of ventricular septal defect and/or atrial septal defect. Except some of congenital heart disease, a middle line sternotomy incision was made in all cases. Anterio-lateral thoracic incision on right side was made in some of congenital heart disease.

Heparin was given in 400 unit/kg dosage before ascending aortic intubation central line for systemic heparinization and additional dosage was given (80 u/kg) per 30 min to maintain activated coagulation time > 500 s. Systemic hypothermia was initiated after CPB started and target temperature was achieved according to the surgery classification. CPB flows were maintained between 2.2 ~ 2.5 L/min/m2. Mean blood pressure was maintained between 45 ~ 75 mmHg during the bypass. Myocardial protection during CPB consisted of an antegrade cold blood cardioplegia administered at regular intervals (20 minutes), local hypothermia, and systemic hypothermia. After aortic clamp removed, inotropic agents were used according to cardiac performances and hemodynamic status. Weaning from CPB was conducted when cardiac main procedure finished and hemodynamic status was stable and agreement with surgeon achieved.

All statistical analysis was performed in SPSS software. Continuous measurement data was shown as mean ± SD and compared using student’s t-test. Semiquantitative data and numerous data were compared using Chi-square test. Multivariate data was analyzed by logistic regression analysis using a stepwise backward method. p < 0.05 was considered as statistically significant.

Results

Among the 182 recruited patients, 4 were excluded because of re-operation for bleeding and 2 were excluded because of refusal to neuropsychological evaluation. The final number of patients included in the analysis was 176. The general demographic data of patients were shown in Table 1, including age, gender, body mass index, education background, surgery type, previous history of hypertension, ASA classification, NYHA cardiac function class and ejection fraction. Anesthesia and surgery related information were also listed, such as position, surgery and anesthesia duration, CPB and cross-clamp duration, rewarming duration, dose of anesthetics (Table 2). According to MMSE results, there were 58 patients meeting the diagnosis of POCD (33.0%).
Table 1

Demographics of patients

Items

Value

Age (years)

41.7 ± 18.7

Gender (M/F)

94/82

BMI

21.0 ± 3.9

Education background

 

  <3 years (%)

14 (8.0)

  3-6 years (%)

50 (28.4)

  7-9 years (%)

64 (36.4)

  9-12 years (%)

32 (18.2)

  >12 years (%)

16 (9.1)

Surgical type

 

  Congenital disease(%)

52 (29.5)

  Valvular disease (%)

86 (48.9)

  Aorta disease (%)

34 (19.3)

  Tumor (%)

4 (2.3)

Hypertension (%)

26 (14.8)

ASA (II/III/IV)

102/56/18

NYHA (I/II/III/IV)

21/97/50/8

EF (%)

61.4 ± 8.3

NOTE. Data were expressed as number (%) or mean ± standard deviation. M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologists score; NYHA, New York Heart Association cardiac functional classification; EF, ejection fraction.

Table 2

Surgical and anesthetic data

Items

Value

Head-down position (%)

142 (80.7)

Surgical duration (h)

3.3 ± 1.0

Anesthesia duration (h)

4.1 ± 1.2

CPB duration (min)

89.3 ± 33.1

CC duration (min)

50.6 ± 23.1

Rewarming duration (min)

33.6 ± 1.6

Midazolam dose (mg)

10.6 ± 2.9

Etomidate dose (mg)

25.4 ± 9.9

Sufentanil dose (μg)

262.8 ± 107.1

Sevoflurane concentration (%)

2.0 ± 1.1

NOTE. CPB, cardiopulmonary bypss; CC, cross-clamp.

Univariate analysis

Univariate analysis was performed to find any potential risk factor of POCD (Table 3). Patients with POCD were significantly older than non-POCD patients (p = 0.040). More patients in POCD group belonged to ASA classification 3 and 4. Duration of surgery, anesthesia, CPB and cross-clamp were closely related to each other and all of them were correlated with POCD (p < 0.01). Non-POCD patients had a higher concentration of sufentanil and longer rewarming duration (p < 0.01), the time interval from the start to finish of body temperature rewarming. Surgery type was less likely to impact the incidence of POCD (p = 0.051).
Table 3

Univariate analysis of early POCD after non-CABG cardiac surgery

Items

POCD

Non-POCD

P value

Age

45.9 ± 17.9

39.6 ± 19.8

0.040

Gender (M/F)

32/26

62/56

0.742

BMI

20.5 ± 3.6

21.2 ± 3.9

0.239

Education background

  

0.122

  <3 years (%)

3

11

 

  3-6 years (%)

22

28

 

  7-9 years (%)

22

42

 

  9-12 years (%)

10

22

 

  >12 years (%)

2

14

 

Surgical type

  

0.051

 Congenital disease

10

42

 

  Valvular disease (%)

32

54

 

  Aorta disease (%)

14

20

 

  Tumor (%)

2

2

 

Hypertension (%)

10

16

0.518

ASA (II/III/IV)

24/24/10

78/32/8

0.005

NYHA (I/II/III/IV)

10/33/18/2

11/66/32/6

0.309

EF (%)

61

63

0.688

Hypertension (%)

62.8 ± 8.5

60.8 ± 8.1

0.173

Head-down position (%)

15.4

10.9

0.419

Surgical duration (h)

3.7 ± 1.4

3.1 ± 0.8

0.003

Anesthesia duration (h)

4.6 ± 1.5

3.8 ± 0.8

0.001

CPB duration (min)

105.2 ± 37.8

82.1 ± 28.0

<0.001

CC duration (min)

61.3 ± 26.0

45.8 ± 19.9

<0.001

Rewarming duration (min)

32.8 ± 2.2

34.0 ± 1.1

<0.001

Midazolam dose(mg)

10.3 ± 3.5

10.7 ± 2.6

0.502

Etomidate dose (mg)

27.2 ± 11.1

24.4 ± 9.1

0.108

Sufentanil dose (μg)

282.2 ± 118.8

252.8 ± 99.8

0.122

NOTE. Date are expressed as number (%) or mean ± standard deviation. M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologists score; NYHA, New York Heart Association cardiac functional classification; EF, ejection fraction. CPB, cardiopulmonary bypass; CC, cross-clamp. Variables with a p < 0.01 was included in the multivariate analysis.

Multivariate analysis

The factors with a p value lower than 0.1 in the univariate analysis were screened for multivariate analysis, including age, surgery type, ASA classification, surgery duration, anesthesia duration, CPB duration, cross-clamp duration, rewarming duration and sevoflurane concentration.

Among these factors, continuous measurement data were converted to discrete data and then all the factors were admitted into logistic regression analysis. Finally, the independent risk factors for POCD were age (p = 0.043), cross-clamp duration (p = 0.028) and sevoflurane concentration (p < 0.001) (Table 4).
Table 4

Multivariate analysis of early POCD after non-CABG cardiac surgery

Items

Coefficient

P value

OR (95% CI)

Age

0.29

0.043

1.34 (1.01-1.78)

Anesthesia duration

0.44

0.053

1.55 (1.00-2.41)

CC duration

0.77

0.028

2.167 (1.09-4.32)

Sevoflurane concentration

-0.68

0.000

0.505 (0.34-0.74)

NOTE. CC, cross-clamp.

Discussion

POCD is a common complication of cardiovascular surgery affecting patients’ outcomes. Early POCD will complicate the medical disposal, and prolong the hospitalization. The exact etiology of POCD remains unclear. The most accepted risk factors are periopertive hypoperfusion and microembolism. As a significant unphyisological circulation, CPB plays an important role to introduce the both predisposing factors to POCD [20]. Previous study revealed that the use of CPB is an independent factor associating with POCD after CABG [5, 7, 9]. There are few researches on general incidence of POCD after non-CABG but on pump cardiovascular surgery [10]. However, most of cardiovascular surgeries are performed on pump. As the patients went on the same predisposing factor, CPB, whether they confront with same risk to the POCD remains unknown. Moreover, although the incidence of cognitive dysfunction after CABG in Chinese population was reported by Liu et al. [21], there is no report on general incidence of POCD in Chinese population undergoing non-CABG cardiovascular surgery. So the study was focused on incidence of POCD after cardiovascular surgery involving non-CABG cardiac surgery, as well as the perioperative risk factors in Chinese population.

In the present study, the general incidence of early POCD was 33.0% within 7 days after surgery and the difference of POCD incidences after different surgery was not statistically significant. Although incidence of POCD after aortic and tumor surgery seemed higher than that of other types of surgery, the phenomenon might be due to longer surgery and CPB duration. Head-down position was always applied during aorta opening to prevent cerebral air emboli in many centers in China. However, our results showed no correlation between head-down position and incidence of POCD, which is in accordance with a previous study which revealed that cerebral microemboli were not significant related to the occurrence of POCD in Chinese population [21].

Cross-clamp duration was recognized to be an independent risk factor for POCD after non-CABG cardiac surgery, but not duration of CPB, anesthesia or surgery. Circulation status during cross-clamp period was special because of completely artificial circulation. Two causes of the perfusion status might contribute to POCD during cross-clamp period. First, cross-clamp might lead to cerebral hypoperfusion during cross-clamp period, which was deemed as an important factor of POCD in non-cardiac surgery. Ogasawara et al. reported that cognitive dysfunction without neurologic deficits were associated with perioperative hypoperfusion in carotid endarterectomy [22]. Unfortunately, the optimal perfusion pressure during CPB for cerebral perfusion remains unclear. Some studies suggested that higher perfusion pressure might be benefit for neurologic deficit patients, but some other studies demonstrated that perfusion pressures too high or too low were both harmful to cognitive function [23]. Therefore, the potentially inappropriate perfusion pressure might be the reason that longer cross-clamp duration lead to POCD. Second, non-pulsate CPB, the only circulation during the aortic cross-clamp period, might result in poorer tissue perfusion than physiological pulsate flow, which was the other reason of POCD during cross-clamp period [24]. In general, ischemia or hypoxia induced by hypoperfusion or non-pulsate flow was a key contributor to POCD.

The etiology of POCD by hypoperfusion is still unknown. But it can be inferred that hypoperfusion will make energy deprived in perfusion area. Many proapoptotic genes were activated by downregulation of the ATP level in mitochondrion. Typically, anti-apoptosis members of Bcl-2 protein family became activated and act on the mitochrondial to release cytochrome C, then apoptosis was induced. More severe energy exhaustion would make the cells directly to necrosis [25]. On the other hand, restoration of perfusion will induce humoral and cellular activation, leading to a systemic inflammatory response, which may contribute to incidence of POCD [26].

Interestingly, sevoflurane was found to be an independent factor for POCD in the present research. There were many reports about sevoflurane preconditioning for cardiac protection in cardiac surgery. Sevoflurane and other volatile anesthetic have been showed to reduce myocardial infarction and, perioperative death and postoperative inotrope drug dosage. But effect of sevoflurane on neural system was still controversial. Animal study revealed that sevoflurane impaired memory consolidation in rats [27]. However, it was also reported that postconditioning of sevoflurane protected against focal cerebral ischemia in rats, as demonstrated that sevoflurane preconditioning attenuated neurological deficit score, cerebral infarct volume and brain edema [28]. Several clinical trials favored inhalational anesthetics which showed a protective effect against cognitive dysfunction. Delphin et al. [29] revealed that patients undergoing fast-track anesthesia with sevoflurane as prime maintenance anesthetic for OPCAB were extubated earlier and allowing assessment of cognitive and neurologic function earlier than those receiving isoflurane. A recently published randomized controlled study showed that desflurane leaded to a reduced incidence of early POCD before discharge from hospital among patients underwent coronary artery bypass surgery [30]. Therefore, it was not strange that our present study showed that higher concentration of sevoflurane concentration was associated with a lower incidence of POCD after non-CABG surgery. But whether sevoflurane was protective against POCD should be further confirmed by well-designed randomized controlled trials.

Conclusion

In summary, the incidence of POCD is relatively high after non-CABG cardiovascular surgery in Chinese population. Advanced age, longer aortic cross-clamp duration are the potential risk factors, while higher sevoflurane concentration is a potential protective factor.

Notes

Abbreviations

POCD: 

Postoperative cognitive dysfunction

CABG: 

Coronary-artery-bypass-graft

MMSE: 

Mini-Mental State Examination

CPB: 

Cardiopulmonary bypass

EEG: 

Electroencephalograph

PAC: 

Pulmonary artery catheter.

Declarations

Authors’ Affiliations

(1)
Department of Anesthesiology and Intensive Care Medicine, Changhai hospital, Second Military Medical University
(2)
Department of Cardiothoracic surgery, Changhai hospital, Second Military Medical University

References

  1. Newman S: The incidence and nature of neuropsychological morbidity following cardiac surgery. Perfusion. 1989, 4: 93-100. 10.1177/026765918900400203.View ArticleGoogle Scholar
  2. Gill R, Murkin JM: Neuropsychologic dysfunction after cardiac surgery: What is the problem?. J Cardiothorac Vasc Anesth. 1996, 10: 91-98. 10.1016/S1053-0770(96)80183-2.View ArticlePubMedGoogle Scholar
  3. Smith PL, Newman SP, Ell P: Cerebral consequence of cardiopulmonary bypass. Lancet. 1986, 8485: 823-825.View ArticleGoogle Scholar
  4. Müllges W, Babin-Ebell J, Reents W: Cognitive performance after coronary artery bypass grafting: a follow-up study. Neurology. 2002, 59: 741-743. 10.1212/WNL.59.5.741.View ArticlePubMedGoogle Scholar
  5. Selnes MA, Grega LM, Borowicz RM: Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg. 2003, 75: 1377-1386. 10.1016/S0003-4975(03)00021-3.View ArticlePubMedGoogle Scholar
  6. Rasmussen LS: Postoperative cognitive dysfunction: Incidence and prevention. Best Pract Res Clin Anaesthesiol. 2006, 20: 315-330.View ArticlePubMedGoogle Scholar
  7. Bendszus M, Reents W, Franke D: Brain damage after coronary artery bypass grafting. Arch Neurol. 2002, 59: 1090-1095. 10.1001/archneur.59.7.1090.View ArticlePubMedGoogle Scholar
  8. Knipp SC, Matatko N, Wilhelm H: Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. Eur J Cardiothorac Surg. 2004, 25: 791-800. 10.1016/j.ejcts.2004.02.012.View ArticlePubMedGoogle Scholar
  9. Restrepo L, Wityk RJ, Grega MA: Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke. 2002, 33: 2909-2915. 10.1161/01.STR.0000040408.75704.15.View ArticlePubMedGoogle Scholar
  10. Zimpfer D, Czerny M, Kilo J, Kasimir MT, Madl C, Kramer L, Wieselthaler GM, Wolner E, Grimm M: Cognitive deficit after aortic valve replacement. Ann Thorac Surg. 2002, 74: 407-412. 10.1016/S0003-4975(02)03651-2.View ArticlePubMedGoogle Scholar
  11. Vanninen R, Äikiä M, Könönen M: Subclinical cerebral complications after coronary artery bypass grafting. Arch Neurol. 1998, 55: 618-627. 10.1001/archneur.55.5.618.View ArticlePubMedGoogle Scholar
  12. Newman MF, Mathew JP, Grocott HP: Central nervous system injury associated with cardiac surgery. Lancet. 2006, 368: 694-703. 10.1016/S0140-6736(06)69254-4.View ArticlePubMedGoogle Scholar
  13. Selnes OA, Goldsborough MA, Borowicz LM: Neurobehavioural sequelae of cardiopulmonary bypass. Lancet. 1999, 353: 1601-1606. 10.1016/S0140-6736(98)07576-X.View ArticlePubMedGoogle Scholar
  14. Suwa M, Ito T: Correlation between cognitive impairment and left ventricular diastolic dysfunction in patients with cardiovascular diseases. Int J Cardiol. 2009, 136: 351-354. 10.1016/j.ijcard.2008.04.099.View ArticlePubMedGoogle Scholar
  15. Hudetz JA, Patterson KM, Iqbal Z: Metabolic syndrome exacerbates short-term postoperative cognitive dysfunction in patients undergoing cardiac surgery: results of a pilot study. J Cardiothorac Vasc Anesth. 2011, 25: 282-287. 10.1053/j.jvca.2010.06.008.View ArticlePubMedGoogle Scholar
  16. Mathisen L, Andersen MH, Hol PK: Preoperative cerebral ischemic lesions predict physical health status after on-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2005, 130: 1691-1697. 10.1016/j.jtcvs.2005.08.008.View ArticlePubMedGoogle Scholar
  17. Moller JT, Cluitmans P, Rasmussen LS: Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 1998, 351: 857-861. 10.1016/S0140-6736(97)07382-0.View ArticlePubMedGoogle Scholar
  18. Feldmann E, Daneault N, Kwan E: Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990, 40: 1541-1545.View ArticlePubMedGoogle Scholar
  19. Leung SY, Ng TH, Yuen ST: Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke. 1993, 24: 779-786. 10.1161/01.STR.24.6.779.View ArticlePubMedGoogle Scholar
  20. Kilo J, Czerny M, Gorlitzer M: Cardiopulmonary bypass affects cognitive brain. Ann Thorac Surg. 2001, 72: 1926-1932. 10.1016/S0003-4975(01)03199-X.View ArticlePubMedGoogle Scholar
  21. Liu YH, Wang DX, Li LH: The effects of cardiopulmonary bypass on the number of cerebral microemboli and the incidence of cognitive dysfunction after coronary artery bypass graft surgery. Anesth Analg. 2009, 109: 1013-1022. 10.1213/ane.0b013e3181aed2bb.View ArticlePubMedGoogle Scholar
  22. Ogasawara K, Inoue T, Kobayashi M: Cognitive impairment associated with intraoperative and postoperative hypoperfusion without neurologic deficits in a patient undergoing carotid endarterectomy. Surg Neurol. 2006, 65: 577-581. 10.1016/j.surneu.2005.07.011.View ArticlePubMedGoogle Scholar
  23. Kellermann K, Jungwirth B: Avoiding Stroke During Cardiac Surgery. Semin Cardiothorac Vasc Anesth. 2010, 14: 95-101. 10.1177/1089253210370902.View ArticlePubMedGoogle Scholar
  24. Hindman BJ: Pulsatile versus nonpulsatile flow.No difference in cerebral blood flow or metabolism during normothermic cardiopulmonary bypass in rabbits. Anethesiology. 1995, 82: 241-10.1097/00000542-199501000-00029.View ArticleGoogle Scholar
  25. Dirnagl U, Meisel A: Endogenous neuroprotection: Mitochondria as gateways to cerebral. Neuropharmacology. 2008, 55: 334-344. 10.1016/j.neuropharm.2008.02.017.View ArticlePubMedGoogle Scholar
  26. Gao L, Taha R, Gauvin D: Postoperative Cognitive Dysfunction After Cardiac Surgery. Chest. 2005, 128: 3664-3670. 10.1378/chest.128.5.3664.View ArticlePubMedGoogle Scholar
  27. Liu XS, Xue QS, Zeng QW: Sevoflurane impairs memory consolidation in rats, possibly through inhibiting phosphorylation of glycogen synthase kinase-3beta in the hippocampus. Neurobiol Learn Mem. 2010, 94: 461-467. 10.1016/j.nlm.2010.08.011.View ArticlePubMedGoogle Scholar
  28. Wang JK, Yu LN, Zhang FJ: Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res. 2010, 1357: 142-151.View ArticlePubMedGoogle Scholar
  29. Delphin E, Jackson D, Gubenko Y, Botea A, Esrig B, Fritz W, Mavridis S: Sevoflurane provides earlier tracheal extubation and assessment of cognitive recovery than isoflurane in patients undergoing off-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2007, 21: 690-695. 10.1053/j.jvca.2006.12.008.View ArticlePubMedGoogle Scholar
  30. Royse CF, Andrews DT, Newman SN: The influence of propofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary artery bypass surgery. Anaesthesia. 2011, 66: 455-464. 10.1111/j.1365-2044.2011.06704.x.View ArticlePubMedGoogle Scholar

Copyright

© Xu et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement